Watts Gwilliam & Co. LLC decreased its stake in The Procter & Gamble Company (NYSE:PG – Free Report) by 15.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,403 shares of the company’s stock after selling 779 shares during the quarter. Watts Gwilliam & Co. LLC’s holdings in Procter & Gamble were worth $710,000 as of its most recent SEC filing.
Several other institutional investors have also recently made changes to their positions in PG. Itau Unibanco Holding S.A. purchased a new stake in Procter & Gamble in the 2nd quarter worth $28,000. Fairway Wealth LLC bought a new position in shares of Procter & Gamble in the second quarter worth about $29,000. RPg Family Wealth Advisory LLC purchased a new stake in shares of Procter & Gamble during the third quarter worth about $33,000. Quest Partners LLC bought a new stake in Procter & Gamble during the 2nd quarter valued at approximately $36,000. Finally, Fairfield Financial Advisors LTD purchased a new position in Procter & Gamble in the 2nd quarter worth approximately $44,000. Institutional investors own 65.77% of the company’s stock.
Procter & Gamble Price Performance
PG opened at $162.07 on Friday. The stock has a market cap of $381.68 billion, a P/E ratio of 27.94, a PEG ratio of 3.70 and a beta of 0.45. The Procter & Gamble Company has a 52-week low of $146.28 and a 52-week high of $180.43. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The business has a fifty day moving average of $169.77 and a 200 day moving average of $169.64.
Analyst Upgrades and Downgrades
A number of brokerages have issued reports on PG. Hsbc Global Res raised shares of Procter & Gamble to a “strong-buy” rating in a report on Friday, October 4th. Wells Fargo & Company cut their target price on shares of Procter & Gamble from $190.00 to $176.00 and set an “overweight” rating for the company in a research note on Tuesday. Royal Bank of Canada reiterated a “sector perform” rating and issued a $164.00 price target on shares of Procter & Gamble in a research note on Monday, October 21st. JPMorgan Chase & Co. raised their price objective on Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research report on Thursday, September 19th. Finally, Piper Sandler assumed coverage on Procter & Gamble in a research report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 target price on the stock. Eight equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $179.75.
Check Out Our Latest Analysis on Procter & Gamble
Insider Transactions at Procter & Gamble
In related news, CEO R. Alexandra Keith sold 1,992 shares of the company’s stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $170.00, for a total transaction of $338,640.00. Following the completion of the sale, the chief executive officer now directly owns 13,783 shares in the company, valued at $2,343,110. This represents a 12.63 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Gary A. Coombe sold 47,847 shares of Procter & Gamble stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total value of $8,604,804.48. Following the completion of the transaction, the chief executive officer now owns 39,977 shares in the company, valued at $7,189,463.68. This trade represents a 54.48 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 75,439 shares of company stock valued at $13,317,460. 0.18% of the stock is currently owned by corporate insiders.
Procter & Gamble Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Read More
- Five stocks we like better than Procter & Gamble
- What is the Australian Securities Exchange (ASX)
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- Want to Profit on the Downtrend? Downtrends, Explained.
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.